The Valley Desk

NCT01732913 · Interventional trial

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Overall registry status Terminated

Phase 3

Conditions Indolent Non-Hodgkin's Lymphomas

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov